{"retracted":false,"update":{"timestamp":1412035200000,"doi":"10.1371/journal.pone.0110069","type":"correction"},"doi":"10.1371/journal.pone.0105638","journal":"PLoS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes"}
